» Authors » Belen Atienza-Mateo

Belen Atienza-Mateo

Explore the profile of Belen Atienza-Mateo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 66
Citations 520
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pulito-Cueto V, Atienza-Mateo B, Batista-Liz J, Sebastian Mora-Gil M, Mora-Cuesta V, Iturbe-Fernandez D, et al.
Mol Med . 2025 Feb; 31(1):70. PMID: 39979794
Background: Lack of understanding of interstitial lung disease (ILD) associated with systemic sclerosis (SSc) and rheumatoid arthritis (RA) hinders the early and accurate identification of these devastating diseases. Current clinical...
2.
Lopez-Maraver M, Serrano-Combarro A, Atienza-Mateo B, Del Val N, Casafont-Sole I, Melero-Gonzalez R, et al.
Semin Arthritis Rheum . 2024 Jul; 68:152517. PMID: 39067148
Background: Evidence on abatacept (ABA) utility for rheumatoid arthritis (RA) - associated interstitial lung disease (ILD) is growing. Clinical trials have shown equivalence in subcutaneous (SC) and intravenous (IV) administration...
3.
Iturbe-Fernandez D, Pulito-Cueto V, Mora-Cuesta V, Remuzgo-Martinez S, Ferrer-Pargada D, Genre F, et al.
Biomedicines . 2024 May; 12(5). PMID: 38791069
Osteopontin (OPN) is a glycoprotein involved in Th1 and Th17 differentiation, and inflammation and tissue remodeling. OPN is a biomarker of disease activity in patients with autoimmune inflammatory conditions. This...
4.
Del Pozo V, Bobolea I, Rial M, Espigol-Frigole G, Solans Laque R, Hernandez-Rivas J, et al.
Front Immunol . 2024 Jan; 14:1310211. PMID: 38250075
Eosinophil-related diseases represent a group of pathologic conditions with highly heterogeneous clinical presentation and symptoms ranging from mild to critical. Both systemic and localized forms of disease are typically treated...
5.
Hannah J, Lawrence A, Martinovic J, Naqvi M, Chua F, Kouranos V, et al.
Rheumatology (Oxford) . 2023 Dec; 63(11):3080-3090. PMID: 38039151
Objectives: The impact of autoantibody profiles on the prognosis for idiopathic inflammatory myositis-associated interstitial lung disease (IIM-ILD) and myositis spectrum ILD with myositis-specific antibodies (MSAs) remains unclear. This retrospective cohort...
6.
Atienza-Mateo B, Fernandez-Diaz C, Vicente-Rabaneda E, Melero-Gonzalez R, Ortiz-Sanjuan F, Casafont-Sole I, et al.
Eur J Intern Med . 2023 Sep; 119:118-124. PMID: 37673775
Objective: To compare the effectiveness of abatacept (ABA) in Rheumatoid Arthritis-associated Interstitial Lung Disease (RA-ILD) according to the radiological patterns of usual (UIP) or non-specific interstitial pneumonia (NSIP). Methods: From...
7.
Pulito-Cueto V, Remuzgo-Martinez S, Genre F, Atienza-Mateo B, Mora-Cuesta V, Iturbe-Fernandez D, et al.
Int J Mol Sci . 2023 Aug; 24(15). PMID: 37569893
Interstitial lung disease (ILD) constitutes the most critical comorbidity in autoimmune diseases (ADs) and its early diagnosis remains a challenge for clinicians. Accordingly, we evaluated whether E-selectin, ICAM-1, and ET-1,...
8.
Genre F, Prieto-Pena D, Pulito-Cueto V, Ocejo-Vinyals J, Atienza-Mateo B, Munoz Jimenez A, et al.
Clin Exp Rheumatol . 2023 Mar; 41(4):910-915. PMID: 36912345
Objectives: Since interleukin-6 (IL-6) is a pivotal proinflammatory cytokine implicated in the pathogenesis of giant cell arteritis (GCA), we aimed to determine the potential association of the functional IL6 -174...
9.
Del Peral-Fanjul A, Atienza-Mateo B, Prieto-Pena D, Pulito-Cueto V, Blanco R
Clin Exp Rheumatol . 2023 Mar; 41(10):2008-2016. PMID: 36912333
Objectives: To assess vascular involvement at different levels in patients with Behçet's disease (BD). Methods: We conducted an observational study of unselected consecutive patients with BD assessed in a national...
10.
Pulito-Cueto V, Genre F, Lopez-Mejias R, Mora-Cuesta V, Iturbe-Fernandez D, Portilla V, et al.
Int J Mol Sci . 2023 Jan; 24(2). PMID: 36674789
The aim of this study was to determine the role of endothelin-1 (ET-1), a molecule involved in multiple vascular and fibrosing abnormalities, as a biomarker of interstitial lung disease (ILD),...